PMID- 33443056 OWN - NLM STAT- MEDLINE DCOM- 20220201 LR - 20220201 IS - 1708-8267 (Electronic) IS - 1081-5589 (Linking) VI - 69 IP - 3 DP - 2021 Mar TI - Graft survival effect of HLA-A allele matching parathyroid allotransplantation. PG - 785-788 LID - 10.1136/jim-2020-001648 [doi] AB - Permanent hypoparathyroidism is an endocrine disease that is mostly associated with the disruption of the parathyroid glands during surgery. Allotransplantation is the most promising approach for treatment particularly for its cost-effective and exact curative potential. Herein our aim was to evaluate human leukocyte antigen (HLA)-A allele matching effect on clinical improvement and graft survival after parathyroid transplantation. We performed parathyroid transplantation between ABO/Rh compatible recipient and an unrelated donor who has chronic kidney disease. Preoperative immunological tests include panel reactive antibody, T-flow cytometry crossmatch, B-flow cytometry crossmatch, autoflow cytometry crossmatch, and complement-dependent cytotoxicity crossmatch tests were performed. After histopathological evaluation, half of the resected parathyroid gland cells were isolated and transplanted to the omentum surface by laparoscopy. The transplantation outcome was followed up throughout 382 days. The recipient discharged 2 days after transplantation without any complication. During follow-up, calcium and vitamin D supplementation reduced to a one-third dose; even the intact PTH levels remained low. However, clinical improvement was observed by serum calcium levels. The recipient still continues with low-dose supplementation after 382 days of post-transplantation. Parathyroid cell transplantation to the omental tissue is the most promising option even with only one allele matching for patients with using lifelong high-dose supplementation. Clinical improvements and long-term effect of HLA-A allele matching should be evaluated with more studies and in larger cohorts as well. CI - (c) American Federation for Medical Research 2021. No commercial re-use. See rights and permissions. Published by BMJ. FAU - Goncu, Beyza AU - Goncu B AUID- ORCID: 0000-0001-6026-8218 AD - Experimental Research Center, Bezmialem Vakif University, Istanbul, Turkey bsgoncu@gmail.com. AD - Parathyroid Transplantation Laboratory, Bezmialem Vakif University, Istanbul, Turkey. FAU - Salepcioglu Kaya, Harika AU - Salepcioglu Kaya H AD - Faculty of Medicine, Department of General Surgery, Bezmialem Vakif University, Istanbul, Turkey. FAU - Yucesan, Emrah AU - Yucesan E AD - Faculty of Medicine, Department of Medical Biology, Bezmialem Vakif University, Istanbul, Turkey. FAU - Ersoy, Yeliz Emine AU - Ersoy YE AD - Faculty of Medicine, Department of General Surgery, Bezmialem Vakif University, Istanbul, Turkey. AD - Parathyroid Transplantation Laboratory, Bezmialem Vakif University, Istanbul, Turkey. FAU - Akcakaya, Adem AU - Akcakaya A AD - Faculty of Medicine, Department of General Surgery, Bezmialem Vakif University, Istanbul, Turkey. AD - Organ Transplantation Unit, Bezmialem Vakif University, Istanbul, Turkey. LA - eng PT - Journal Article DEP - 20201222 PL - England TA - J Investig Med JT - Journal of investigative medicine : the official publication of the American Federation for Clinical Research JID - 9501229 RN - 0 (HLA-A Antigens) RN - SY7Q814VUP (Calcium) SB - IM MH - Alleles MH - Calcium/blood MH - *Graft Survival MH - *HLA-A Antigens MH - Humans MH - *Parathyroid Glands/immunology/surgery MH - Transplantation, Homologous OTO - NOTNLM OT - endocrinology OT - immunologic tests OT - parathyroid hormone OT - transplants COIS- Competing interests: None declared. EDAT- 2021/01/15 06:00 MHDA- 2022/02/02 06:00 CRDT- 2021/01/14 08:46 PHST- 2020/12/09 00:00 [accepted] PHST- 2021/01/15 06:00 [pubmed] PHST- 2022/02/02 06:00 [medline] PHST- 2021/01/14 08:46 [entrez] AID - jim-2020-001648 [pii] AID - 10.1136/jim-2020-001648 [doi] PST - ppublish SO - J Investig Med. 2021 Mar;69(3):785-788. doi: 10.1136/jim-2020-001648. Epub 2020 Dec 22.